Population
Patients with cardiac amyloidosis and aortic stenosis undergoing transcatheter aortic valve replacement
Design
Meta-analysis
We only have this paper's title and publication details.
Read it at the sourceTAVR may be considered in cardiac amyloidosis with aortic stenosis; leaves open need for RCTs to guide long-term management.
No takes yet. Share an insight, caveat, or question.
Jaiswal et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: